Skip to main content

Table 2 Plaque instability and risk factors

From: The risk of carotid plaque instability in patients with metabolic syndrome is higher in women with hypertriglyceridemia

Ā 

Stable plaques (104 cases)

Unstable plaques (82 cases)

Odds ratio (95% CI)

P uni-variate analysis

P multi- variate analysis

Age (yrsā€‰Ā±ā€‰SD)

72.5ā€‰Ā±ā€‰8.1

72.8ā€‰Ā±ā€‰9.3

0.99 (0.96ā€“1.03)

0.80

0.87

Gender

Ā Ā Ā Ā Ā 

Ā Male

65 (62.5%)

66 (80.5%)

0.41 (0.20ā€“0.82)

0.008

0.01

Ā Female

39 (37.5%)

16 (19.5%)

Ā Ā Ā 

Hypertension acc. AHA

90 (86.5%)

72 (87.8%)

1.47 (0.57ā€“3.84)

0.80

0.42

Diabetes

48 (46.2%)

32 (39.0%)

0.70 (0.35ā€“1.39)

0.33

0.31

Smoking habit

23 (22.1%)

17 (20.7%)

0.80 (0.36ā€“1.73)

0.82

0.58

Hypercholesterolemia

17 (16.3%)

12 (14.6%)

0.65 (0.26ā€“1.63)

0.75

0.35

Hypertriglyceridemia

35 (33.7%)

35 (42.7%)

1.80 (0.93ā€“3.63)

0.21

0.10

Low-HDL

48 (46.2%)

38 (46.3%)

1.24 (0.63ā€“2.45)

0.98

0.53

Abdominal obesity

20 (19.2%)

9 (11.0%)

0.47 (0.19ā€“1-17)

0.12

0.11

Statins

74 (71.2%)

54 (65.9%)

0.75 (0.38ā€“1.48)

0.44

0.41

Anti-hypertensive drugs

87 (83.7%)

66 (80.5%)

0.83 (0.36ā€“1.91)

0.57

0.67

Hypertension acc. ESC

62 (59.6%)

50 (61.0%)

1.16 (0.60ā€“2.24)

0.85

0.66

High LDL-C

38 (36.5%)

33 (40.2%)

1.17 (0.64ā€“2.12)

0.61

0.30

Metabolic syndrome

49 (47.1%)

36 (43.9%)

0.91 (0.49ā€“1.71)

0.66

0.77